A new method to select the right treatment for advanced prostate cancer

(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published in the journal JAMA Oncology. The researchers envision that this discovery may eventually result in a test that contributes to a more personalised treatment of the disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news